Manchester Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,791
| Closed | -$37.2K | – | 1201 |
|
|
2025
Q1 | $37.2K | Sell |
1,791
-14
| -0.8% | -$291 | ﹤0.01% | 604 |
|
|
2024
Q4 | $42.5K | Hold |
1,805
| – | – | ﹤0.01% | 568 |
|
|
2024
Q3 | $46.2K | Hold |
1,805
| – | – | 0.01% | 556 |
|
|
2024
Q2 | $42.4K | Hold |
1,805
| – | – | 0.01% | 532 |
|
|
2024
Q1 | $51.9K | Sell |
1,805
-14
| -0.8% | -$403 | 0.01% | 466 |
|
|
2023
Q4 | $59.7K | Hold |
1,819
| – | – | 0.01% | 406 |
|
|
2023
Q3 | $50.7K | Hold |
1,819
| – | – | 0.01% | 414 |
|
|
2023
Q2 | $62K | Buy |
1,819
+165
| +10% | +$5.63K | 0.01% | 394 |
|
|
2023
Q1 | $49.7K | Buy |
1,654
+325
| +24% | +$9.77K | 0.01% | 425 |
|
|
2022
Q4 | $37.5K | Buy |
1,329
+1,301
| +4,646% | +$36.7K | 0.01% | 384 |
|
|
2022
Q3 | $1K | Hold |
28
| – | – | ﹤0.01% | 713 |
|
|
2022
Q2 | $1K | Hold |
28
| – | – | ﹤0.01% | 777 |
|
|
2022
Q1 | $1K | Hold |
28
| – | – | ﹤0.01% | 895 |
|
|
2021
Q4 | $2K | Sell |
28
-190
| -87% | -$13.6K | ﹤0.01% | 811 |
|
|
2021
Q3 | $16K | Sell |
218
-20
| -8% | -$1.47K | ﹤0.01% | 538 |
|
|
2021
Q2 | $22K | Buy |
238
+28
| +13% | +$2.59K | ﹤0.01% | 433 |
|
|
2021
Q1 | $19K | Hold |
210
| – | – | ﹤0.01% | 441 |
|
|
2020
Q4 | $20K | Hold |
210
| – | – | ﹤0.01% | 426 |
|
|
2020
Q3 | $13K | Hold |
210
| – | – | ﹤0.01% | 406 |
|
|
2020
Q2 | $11K | Hold |
210
| – | – | ﹤0.01% | 461 |
|
|
2020
Q1 | $7K | Hold |
210
| – | – | ﹤0.01% | 473 |
|
|
2019
Q4 | $7K | Hold |
210
| – | – | ﹤0.01% | 478 |
|
|
2019
Q3 | $6K | Hold |
210
| – | – | ﹤0.01% | 476 |
|
|
2019
Q2 | $7K | Buy |
+210
| New | +$7K | ﹤0.01% | 501 |
|